Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 tweeters

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?

Article in European Neuropsychopharmacology (March 2023)

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression

Article in Bipolar Disorders (January 2023)

Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions

Article in Neuropsychiatric Disease and Treatment (December 2022)